1Tcrshner SA, Helmstetter. Antinociception produced by mu opioid receptor activation in the amygdala is partly dependent on activation of mu opioid and neurotensin receptors in the ventral periaqueductal gray[J]. Brain research, 2000, 865(1): 17-26.
2Urban MO, Coutinho SV, Gebhart GF. Biphasic modulation of visceral nociception by neurotensin in rat rostral ventromedial medulla[J]. J Pharmacol Exp Ther, 1999, 290:207.
3Dubuc I, Pain C, Suaudeau C, et al. Tolerance to the hypothermic but not to the analgesic effect of [D-Trp11 ] neurotensin during the semichronic intracerebro-ventricular infusion of the peptide in rats[J]. Peptides, 1994, 15(2):303-307.
4Dubuc I, Costentin J, Terranova JP, et al. The nonpeptide neurotensin antagonist, SR 48692, used as a tool to reveal putative neurotensin receptor subtypes [J ] . Br J Pharmacol, 1994, 112(2): 352-4.
6Slusher BS, Zacco AE, Maslanski JA, et al. The cloned neurotensin receptor mediates cyclic GMP formation when cocxpres sed with nitric oxide synthase cDNA[J ]. Mol Pharmacol, 1994, 46(1):115-21.
7Lapchak PA, Araujo DM, Quirion R, et al. Neurotensin regulation of endogenous acetylcholine release from rat striatal slices is independent of dopaminergic tone[J]. J Neurochem, 1991, 56(2) :651-657.
8Rakovska A, Giovannini MG, Della Corte L, et al. Neurotensin modulation of acetylcholine and GABA release from the rat hippocampus: an in vivo microdialysis study[J]. Neurochem Int,1998, 33 (4): 335-340.
9Jolas T, Aghajanian GK. Neurotensin and the serotonergic system [J]. Prog Neurobiol, 1997, 52(6) :455-68.
10Leonetti M, Brun P, Sorry F, et al. The neurotensin receptor antagonist SR 142948A blocks the efflux of dopamine evoked in nucleus accumbens by neurotensin ejection into the ventral tegmental area[J ]. Naunyn Schmiedebergs Arch Pharmacol, 2002, 365(6) :427-433.
